Uncategorised - European Medical Journal

Brain Imaging Reveals Key Changes in Opioid Use Disorder Patients: RSNA 2024

Imaging methods reveal brain alterations caused by opioid use.

New Insights into Depression: Skull Bone Marrow, Sinuses, and Inflammation

Imaging reveals how skull regions mediate brain-periphery immune crosstalk in depression, uncovering new therapeutic targets.

Need for Diverse Populations in Epilepsy Research: AES 2024

The lack of diversity not only limits equitable care but also hinders scientific understanding of epilepsy.

No Benefit from Chest Wall Irradiation in Intermediate-Risk Breast Cancer: SABCS 2024

Avoiding chest wall irradiation post-mastectomy is safe for most intermediate-risk breast cancer patients, improving quality of care.

Dark Chocolate Linked to Lower Risk of Type 2 Diabetes

Consuming dark chocolate linked to reduced risk of type 2 diabetes, study finds.

Gut Microbiome Modulation: Transforming Melanoma Immunotherapy

Fibre-rich diets promote beneficial microbiota, producing short-chain fatty acids that enhance immune functions.

Deep Learning Tool Predicts Immunotherapy Efficacy in Lung Cancer

A novel deep learning-based radiomic biomarker could significantly enhance prediction of response to immune checkpoint inhibitors (ICIs) in patients with advanced non-small cell lung cancer (NSCLC).

What Do Migraine And Gastrointestinal Disorders Have In Common?

A study has uncovered significant genetic overlap between migraine and several gastrointestinal (GI) disorders, suggesting shared underlying neurologic mechanisms despite diverse etiologies.

The Role of Biomarkers in Frailty and Liver Health

Frailty has emerged as a therapeutic target in advanced chronic liver disease management, with non-pharmacological interventions showing promise.

Long-Term Success with Cyclophosphamide in Refractory Myasthenia Gravis

Cyclophosphamide offers rapid remission and long-term benefits in high-risk myasthenia gravis, reducing corticosteroid reliance and injectable therapies.